---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-002723"
form_type: "8-K"
ticker: "ELAN"
cik: "0001739104"
company_name: "Elanco Animal Health Inc"
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:54:25.564916+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Elanco to present at J.P. Morgan Healthcare Conference; no new material information disclosed

## Summary
- Presentation reiterates innovation, portfolio, productivity strategy, pipeline, financial outlook, and executive team insights from December Investor Day.
- No new financial guidance or specific metrics provided; 2025 outlook remains as of November 5, 2025, and reaffirmed December 9, 2025.
- Q4 2025 results expected to be announced in February 2026; no update in this filing.

## SEC filing metadata
- accession: 0001104659-26-002723
- form_type: 8-K
- ticker: ELAN
- cik: 0001739104
- company_name: Elanco Animal Health Inc
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1739104/000110465926002723/0001104659-26-002723-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1739104/000110465926002723/tm262899d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-002723
- JSON: https://secwatch.observer/filing/0001104659-26-002723.json
- Plain text: https://secwatch.observer/filing/0001104659-26-002723.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.